Dimitrios will share an insight into the work of the clinicians and researchers who deliver excellence and innovation in research, clinical practice, education and training to make a real difference to women's health locally, nationally and worldwide.

Elaine has a particular interest in how events early in life interact with adult lifestyle factors to determine how we age. Elaine will present an insight into The Global Longitudinal Study of Osteoporosis in Women (GLOW).

Illingworth Research Group (a Syneos Health company) provide a range of patient focused clinical services to the pharmaceutical, healthcare, biotechnology and medical device industries. Juliet has over 20 years' experience within clinical research and has recently specialised in neurology research, in particular, the field of multiple sclerosis.

Verso Biosense are focused on improving women's health with a device that provides a wireless and battery-free solution for long-term monitoring of physiological conditions in the uterus over a multi-day period. Jo will give an overview of how Verso has evolved and cover some of the challenges they've faced in raising funding and the rewards they've had in developing a technology that does something totally novel in an under-served space.

Adora Health are building the world's first AI Menopause coach. Ed will present how Adora uses Conversational AI to provide scalable, personalised support the instant a woman needs it. He will discuss the hidden scale of the menopause and it's impact in working women. Look at how Adora can provide that discreet support about sensitive issues and the progress the team has made in getting to market.

Mithra Pharmaceuticals are a Belgian biotech company dedicated to transforming Women's Health by offering new choices through innovation, with a particular focus on contraception and menopause.

Digostics is dedicated to the prevention and harm reduction of diabetes and cardiovascular disease through home diagnostics. Digostics’ wireless diagnostics platform combines disposable electronic tests, mobile apps and the cloud to enable new services designed to help patients and healthcare providers work together to prevent disease. Its ground-breaking first product, GTT@home, allows patients to perform an oral glucose tolerance test (OGTT) safely and conveniently at home, and is the only solution providing a home-based alternative to clinic-based OGTT.